| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cara Therapeutics, Inc. | Director | Common Stock | 183K | $137K | $0.75 | Jun 4, 2024 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President and Chief Medical Officer | Restricted Stock Units | 29.7K | $24.9K | $0.84 | Aug 15, 2024 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President and Chief Medical Officer | Common Stock | 21K | $17.7K | $0.84 | Aug 16, 2024 | Direct |
| Seres Therapeutics, Inc. | Executive Vice President and Chief Medical Officer | Stock Option (Right to Buy) | 288K | Feb 14, 2024 | Direct | ||
| Cara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 195K | Jun 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | Aug 15, 2024 | 3 | -$817 | 4 | Aug 19, 2024 | Executive Vice President and Chief Medical Officer |
| CARA | Cara Therapeutics, Inc. | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
| MCRB | Seres Therapeutics, Inc. | May 14, 2024 | 3 | -$883 | 4 | May 17, 2024 | Executive Vice President and Chief Medical Officer |
| MCRB | Seres Therapeutics, Inc. | Feb 14, 2024 | 6 | -$4.75K | 4 | Feb 16, 2024 | Executive Vice President and Chief Medical Officer |
| MCRB | Seres Therapeutics, Inc. | Oct 27, 2023 | 4 | -$5.71K | 4 | Oct 31, 2023 | Executive Vice President and Chief Medical Officer |
| CARA | Cara Therapeutics, Inc. | Jun 1, 2023 | 2 | $0 | 4 | Jun 5, 2023 | Director |
| MCRB | Seres Therapeutics, Inc. | Feb 3, 2023 | 2 | $0 | 4 | Feb 7, 2023 | Executive Vice President and Chief Medical Officer |
| CARA | Cara Therapeutics, Inc. | Jan 2, 2023 | 1 | $0 | 4 | Jan 19, 2023 | Director |
| CARA | Cara Therapeutics, Inc. | Nov 1, 2022 | 0 | $0 | 3 | Nov 10, 2022 | Director |
| MCRB | Seres Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 8, 2022 | Executive Vice President and Chief Medical Officer |